Standout Papers

Gemcitabine Plus<i>nab</i>-Paclitaxel Is an Active Regimen in Patients With Advanced Pancreatic C... 2011 2026 2016 2021 807
  1. Gemcitabine Plusnab-Paclitaxel Is an Active Regimen in Patients With Advanced Pancreatic Cancer: A Phase I/II Trial (2011)
    Daniel D. Von Hoff, Ramesh K. Ramanathan et al. Journal of Clinical Oncology
  2. Autophagy Is Critical for Pancreatic Tumor Growth and Progression in Tumors with p53 Alterations (2014)
    Annan Yang, N.V. Rajeshkumar et al. Cancer Discovery

Immediate Impact

26 from Science/Nature 95 standout
Sub-graph 1 of 16

Citing Papers

Post‐translational modifications of histones: Mechanisms, biological functions, and therapeutic targets
2023 Standout
Pancreatic cancer: Advances and challenges
2023 Standout
33 intermediate papers

Works of N.V. Rajeshkumar being referenced

Therapeutic Targeting of the Warburg Effect in Pancreatic Cancer Relies on an Absence of p53 Function
2015
Autophagy Is Critical for Pancreatic Tumor Growth and Progression in Tumors with p53 Alterations
2014 Standout
and 12 more

Author Peers

Author Last Decade Papers Cites
N.V. Rajeshkumar 2752 1869 1324 43 4.2k
Cristina R. Ferrone 1734 1816 1431 28 4.5k
Patrick Hermann 3384 2479 1255 50 4.7k
Ya’an Kang 1414 2141 1625 53 3.8k
Vijaya Ramachandran 2024 1950 919 44 3.9k
Thiruvengadam Arumugam 2382 2793 1303 42 5.0k
Oriol Casanovas 2303 3784 2070 70 6.1k
Aaron Pollett 3798 2546 1699 84 6.7k
Adriana Eramo 1876 2516 1040 48 4.1k
Scott J. Dylla 2661 2451 935 34 4.6k
Tatjana Crnogorac‐Jurcevic 1805 2171 1202 75 4.0k

All Works

Loading papers...

Rankless by CCL
2026